en

PRODUCT DETAIL

Sunitinib Vipharm 50 mg

Code 2469E
MA number 44/0296/22-S
Product Form: cps dur 30x50 mg (fľ.HDPE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX01 Sunitinib
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 12.12.2022
Validity: 12.12.2027
PIL: PIL_Sunitinib Vipharm_12,5mg, 25mg, 50mg_12_2022.pdf  
SPC: SPC_Sunitinib Vipharm 50 mg_03.2024.pdf  
Safety feature Yes
Data update: 14.03.2024
eu-flag.png sk-flag.png